Company intelligence / Profile preview

Inserm Transfert

Ownership: Private
Development stage: Other

Overview

Inserm Transfert acts as the private subsidiary and technology transfer office of France’s National Institute for Health and Medical Research (Inserm), managing economic value creation and knowledge transfer from academic research to industry. It supports innovation in human health through licensing deals, industrial partnerships, startup incubation/funding initiatives like Inserm Transfert Initiative seed fund, and assistance with clinical/translational research. The company has enabled successful commercialization of innovations such as new antibiotics targeting resistant bacteria.

Therapeutic areas: Infectious Diseases
Modalities: Small moleculeBiologicDiagnostic testBiomarker-based technologies
Industry: Drug Discovery Services

Partnerships

Multiple industrial partners via licensing agreements

Beyond the preview

Go deeper on Inserm Transfert.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inserm Transfert.